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BACKGROUND. Gastric cancer incidence rates for American Indians and Alaska
Natives (AI/ANs) historically have exceeded those for non-Hispanic whites
(NHWs). Previous reports may have underestimated the true burden of gastric
cancer in AI/AN populations because of misclassification of AI/AN race in cancer
registries.
METHODS. Population-based cancer registry data from 1999 through 2004 were
used to describe gastric cancer incidence in AI/ANs and NHWs in the US. To
address misclassification of race, registry data were linked with Indian Health
Service administrative records, and analyses were restricted to residents of Con-
tract Health Service Delivery Areas (CHSDA). Disease patterns were assessed for
6 geographic regions and for all regions combined. Rates were expressed per
100,000 population and were age-adjusted to the 2000 US standard population.
RESULTS. In CHSDA counties, gastric cancer incidence rates for AI/ANs were
higher than the rates for NHWs across most regions. For both sexes combined,
AI/AN rates ranged from 6.1 in the East region to 24.5 in Alaska; there was rela-
tively little regional variation in NHW rates. Most patients with gastric cancer
were diagnosed with late-stage disease, regardless of race, age, or sex. In some
regions, cancer rates in the central/distal portions of the stomach were higher
among AI/ANs than among NHWs, whereas rates in the proximal stomach were
similar between the 2 populations.
CONCLUSIONS. AI/ANs are generally at greater risk for gastric cancer than NHWs.
Relatively high rates of cancer in the central/distal portions of the stomach
among AI/ANs in some geographic regions may indicate a disproportional bur-
den of Helicobacter pylori-associated disease. Cancer 2008;113(5 suppl):1225–33.
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T here is wide geographic variation in the occur-rence of gastric cancer.1-3 Economically develop-
ing countries generally have higher incidence and
mortality rates of the disease than developed coun-
tries,3 with the notable exceptions of Japan and
Korea. Gastric cancer claims an estimated 857,000 lives
each year worldwide and is second only to hepatocellu-
lar carcinoma as a leading cancer cause of death.1-3
For reasons that are not understood fully, gastric
cancer incidence and mortality rates declined in
many countries over the course of the 20th century.4
Possible reasons that have been hypothesized to
explain the decline have included increased fruit and
vegetable consumption, decreased intake of foods
preserved with salt or by smoking, declines in salt
intake, widespread availability of refrigeration, and
the reduced prevalence of Helicobacter pylori infec-
tion. In the US, gastric cancer mortality rates per
100,000 among males declined from 46.3 in 1930 to
5.9 in 2004, and the rates among females declined
from 35.2 in 1930 to 3.0 in 20045,6 Nonetheless, gas-
tric cancer remains a highly fatal condition, because
the majority of patients are diagnosed with late-stage
disease that is difficult to treat.7,8
Previous studies have demonstrated that AI/AN
populations are at higher risk for this disease than
the general US population.9,10 In the Southwestern
US and in Alaska, incidence rates for gastric cancer
among AI/AN populations remain high despite
declining rates in other racial/ethnic populations
from the same regions.9,10 However, it is likely that
misclassification of AI/ANs as other races in central
cancer registries11-14 resulted in an underestimate of
the true burden of gastric cancer in these populations.
This report provides a comprehensive overview
of the burden of gastric cancer among AI/AN popu-
lations in the US from both nationwide and regional
perspectives. Rates for NHW populations are pre-
sented for comparison. To minimize the effects of
the misclassification of race for AI/ANs, cancer regis-
try data were linked with Indian Health Service (IHS)
patient services records, and the analyses were re-
stricted to residents of counties where such linkages
were most efficacious.
MATERIALS AND METHODS
Cancer Cases
Incident gastric cancer cases diagnosed during 1999
through 2004 were identified from population-based
registries that participate in the National Cancer
Institute Surveillance, Epidemiology, and End Results
(SEER) Program15 and/or the Centers for Disease
Control and Prevention National Program of Cancer
Registries (NPCR).16 During the period covered by
this study, participating registries classified tumor
histology, tumor behavior, and primary cancer site
(ie, topography) according to the Third Edition of the
International Classification of Diseases for Oncology
(ICD-O).17
Eligible cases included all malignant neoplasms
of the stomach (ICD-O topography codes C16.0-
C16.9 and ICD-O behavior code 3). Lymphomas
(ICD-O histology codes 9590-9769), mesothelioma
(ICD-O histology codes 9050-9055), and Kaposi sar-
coma (ICD-O histology code 9140) were excluded
from the analysis. Benign and in situ tumors (ICD-O
behavior codes 0 and 2, respectively) also were
excluded along with tumors of uncertain or unknown
behavior (ICD-O behavior code 1).
Cancer registries usually document AI/AN ances-
try from statements in medical and vital records.
However, previous studies have demonstrated that
registries often misclassify AI/ANs as other races.11-14
For the current analysis, cancer registry records were
linked with IHS patient services files to address this
problem, because AI/AN individuals must provide
proof of membership in a federally recognized tribe
to receive healthcare from the IHS.18
IHS provision of healthcare to AI/AN populations
is considered to be greatest in Contract Health Ser-
vice Delivery Area (CHSDA) counties, which gener-
ally are defined as those counties that contain or are
adjacent to federally recognized tribal reservations
and/or trust lands. There is evidence that AI/AN race
misclassification occurs less often in CHSDA coun-
ties.19 For this reason, 1 set of incidence rates was
calculated for residents of all US counties, and a sec-
ond set of rates was calculated for residents of
CHSDA counties. Figure 1 illustrates the incidence
rates calculated for each of 6 IHS regions (Alaska, Pa-
cific Coast, Northern Plains, Southern Plains, South-
west, and East) and for all regions combined. These
IHS regions were chosen because they are consistent
with previous reports of regional patterns of specific
health outcomes and disease risk factors for AI/
ANs.20-22 Approximately 56% of the US AI/AN popu-
lation resides in CHSDA counties. This proportion
varies by IHS region: Alaska, 100%; East, 13.1%;
Northern Plains, 59%; Southern Plains, 64.1%; Pacific
Coast, 55.6%; Southwest, 87.5%. Additional details
regarding CHSDA and IHS and the data sources and
methods used for this analysis are provided else-
where.18
Standards for coding stage of disease at diagnosis
changed during the period of this study (1999-2004).
To avoid incomparability among the staging
schemes,23 the analysis of stage of disease at diagno-
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sis was restricted to incident cases diagnosed during
the years 2001 through 2003 and coded according to
SEER Summary Stage 2000.24 The staging categories
were as follows: localized for disease that was re-
stricted to the stomach, regional for disease that
extended directly into organs and areas adjacent to
the stomach, and distant for disease that had metas-
tasized to portions of the body not directly adjacent
to the stomach. The undetermined category was for
those whose disease stage at diagnosis could not be
determined.
The site of primary tumor within the stomach
may be related to the underlying etiology of dis-
ease.25 In general, cancers that arise in central/distal
regions of the stomach are associated more closely
with H. pylori infection than cancers in the proximal
stomach. To characterize the topographic distribu-
tion of gastric cancers among AI/ANs and NHWs,
cases were grouped as follows: proximal (cardia and
fundus), distal (gastric body, lesser curvature, greater
curvature, antrum, and pylorus), and overlapping/
unknown (overlapping sites or unknown primary
site). Because most studies of gastric cancer etiology
were focused on adenocarcinoma, our analysis of
cases by anatomic subsite was restricted solely to
patients with adenocarcinoma.
Statistical Analyses
Average annual age-adjusted incidence rates were
calculated by using the direct method.26 Rates were
expressed per 100,000 population and age-adjusted
to the 2000 US standard population.27 Age-specific
rates were calculated for 4 categories: aged <40
years, ages 40 to 49 years, ages 50 to 64 years, and
aged 65 years. Ratios comparing incidence rates
among AI/ANs with those among NHWs were calcu-
lated by dividing the former by the latter, confidence
intervals (CIs) for age-adjusted rates and standar-
dized rate ratios (RR) were calculated based on
methods described by Tiwari et al28 using SEER*Stat
version 6.3.6.29 Denominators for rate calculations
were derived from population estimates from the US
Bureau of the Census.18 Differences between AI/ANs
and NHWs by categories of disease stage were evalu-
ated with the chi-square statistic using standard
modules in SAS software.30
RESULTS
In total, 701 incident gastric cancer cases were diag-
nosed among AI/ANs in participating cancer regis-
tries during the period 1999 through 2004 (Table 1).
A majority of these cases (ie, 606 cases representing
86.5% of all incident cases) were diagnosed among
AI/AN residents of CHSDA counties. Gastric cancer
incidence rates for AI/AN populations residing in
CHSDA counties were uniformly higher than rates
based on AI/AN residents of all counties combined
(except in Alaska, where all counties are designated
as CHSDAs). In contrast, there was little difference in
NHW rates between CHSDA counties and all coun-
ties combined. These findings were consistent with
improved classification of AI/AN cancer cases within
CHSDA counties, which increased rates for AI/ANs
but had minimal effect on rates for NHWs. Con-
sequently, all remaining findings were based on
rates that were calculated for residents of CHSDA
counties.
Among residents of CHSDA counties, gastric can-
cer incidence rates varied by geographic region, race,
and sex (Table 1) (Fig. 2). Rates for AI/AN males
exceeded those for NHW males in all areas except
the East. Rates among AI/AN males ranged from 7.9
in the East to 34.6 in Alaska. In contrast, there was
relatively little regional variation in the rates for
NHW males (range, 7.1-10.1). Rates for AI/AN
females exceeded those for NHW females in all IHS
regions. Similar to males, there was large geographic
variation in incidence among AI/AN females (range,
4.7-17.7) but not among NHW females (range, 3.0-
4.4). Incidence rates were higher for males than
females among both AI/ANs and NHWs in all IHS
regions.
Gastric cancer incidence rates increased with age
(Table 2). For all IHS regions combined, AI/AN rates
exceeded NHW rates at every age. In the Northern
Plains and the Southwest, incidence rates for AI/ANs
were greater than rates for NHWs at every age,
and the differences in Alaska were particularly
FIGURE 1. States and Contract Health Service Delivery Area counties by
Indian Health Service Region.
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pronounced. In the remaining IHS regions, dif-
ferences between AI/ANs and NHWs were less
pronounced, but AI/AN rates tended to be higher.
Males rates exceeded females rates at all ages among
both AI/ANs and NHWs (data not shown).
A majority of gastric cancer cases in both AI/ANs
and NHWs were diagnosed at regional or distant
stages of disease (data not shown). For all IHS
regions combined, AI/ANs were slightly less likely
than NHWs to be diagnosed at early stages of dis-
ease, but these differences did not achieve statistical
significance (P 5 .48). Similar patterns were observed
by geographic region.
For all IHS regions combined, incidence rates of
adenocarcinoma of the proximal stomach generally
were similar for AI/ANs and NHWs, whereas rates of
adenocarcinoma of the central/distal stomach were
higher for AI/ANs than for NHWs (Table 3). However,
this pattern was not uniform across IHS regions or
by sex.
DISCUSSION
Results from this study document dramatic regional
variation in the incidence of gastric cancer among
AI/ANs that was not observed among NHWs residing
in the same geographic areas. AI/ANs in some
regions were diagnosed with a higher proportion of
central/distal gastric cancers, which may indicate
a disproportionate burden of disease because of
H. pylori. It is unlikely that these results were in-
fluenced substantially by the misclassification of
race for AI/ANs, because this issue was addressed by
linking cancer registry data with IHS databases and
by restricting the analysis to residents of CHSDA
counties.
The molecular biology of gastric cancer is com-
plex and varies by gastric site and histology. The inci-
dence of gastric cancer in the stomach cardia, which
accounts for 39% of gastric cancers in US males,31
has been increasing and may involve the same elu-
sive risk factors that are driving increasing rates of
esophageal adenocarcinoma. By comparison, rates
for gastric cancer that affect other stomach sites
have fallen sharply over the last half century in the
US and elsewhere.5
Adenocarcinoma of the stomach commonly is
grouped into 2 primary variants: diffuse and intesti-
nal (well differentiated).32 The incidence of the dif-
fuse type of cancer is similar in most populations,
suggesting that the intestinal type may be responsi-
ble for regional variation. The diffuse type of gastric
cancer is more commonly hereditary, affects younger
patients, and often is associated with blood group A.
Hereditary diffuse gastric cancer follows an autoso-
mal-dominant pattern and involves mutation in the
cell adhesion protein E-cadherin.33 Sporadic, nonher-
editary cases involve bialleic inactivation of the cad-
herin 1 gene CDH1, which encodes for E-caderin.34
By comparison, the intestinal type of gastric cancer
is more common in older individuals, involves the
stomach body and antrum, and mirrors adenocarci-
noma elsewhere in the gastrointestinal tract.35 The
molecular sequence of events leading to the intesti-
nal-type variant is not completely understood, but
appears to follow a chronic gastritis-atrophy-meta-
plasia-dysplasia-carcinoma sequence.36
FIGURE 2. Gastric cancer incidence rates (per 100,000 population and
age-adjusted to the 2000 US standard population) and corresponding 95%
confidence limits for American Indians/Alaska Natives (AI/AN) and non-His-
panic whites (NHW) by sex and Indian Health Service Region and Contract
Health Services Delivery Area counties, US, 1999-2004 (source: cancer
registries in the Centers for Disease Control and Prevention National Program
of Cancer Registries and/or the National Cancer Institute Surveillance, Epide-
miology, and End Results Program).
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Over the past 2 decades, data have been accu-
mulating that support an increasingly strong causal
relation between infection with H. pylori and the
diagnosis of noncardia gastric adenocarcinoma.37-39
Prospective studies in high-risk populations have
reported H. pylori infection as a definite risk factor
for development of gastric cancer.40,41 Infection with
H. pylori results in a chronic, active immune
response that, in the absence of antibiotic-induced
eradication, persists for the life of the host.
H. pylori is a common infection that causes
chronic gastritis and peptic ulcer disease.42,43 It has
been characterized by the International Agency for
Research on Cancer as a Class 1 carcinogen.44 Preva-
lence of H. pylori infection is related chiefly to age
and geographic location. Estimates from the current
National Health and Nutrition Examination Survey
revealed an overall antibody prevalence of 27.1%,
with prevalence estimates approximately 20% greater
for non-Hispanic black, Mexican-American, and
other Hispanic groups.45 Seroprevalence increases
with age, and previous studies in the US have docu-
mented that seroprevalence among individuals aged
60 years is approximately 50%.46-53 Although most
data on H. pylori prevalence in AI/AN communities
are based on work in Alaska,54-57 where prevalence is
approximately 75%, a population-based survey in an
American Indian community in Montana also
revealed a high prevalence (53%).58 In developing
countries, prevalence approaches 90%, with most
individuals infected before age 10 years.59,60
Environmental factors other than H. pylori also
influence the risk of developing gastric cancer. Con-
sumption of fresh fruits and vegetables has been
associated consistently with lowered risk of the dis-
ease.61 Micronutrients, including vitamin E (a-to-
copherol), carotenoids, selenium, and especially
vitamin C (ascorbic acid), all have been linked with
reduced risk, although short-term intervention trials
with these nutrients has not demonstrated protective
effects.62,63 High consumption of salt, nitrite, and
nitrates has been associated consistently with gastric
cancer risk. Refrigeration may have played a role in
reducing gastric cancer rates over the last 60 years by
decreasing reliance on food-preservation methods
such as salt curing, pickling, and meat smoking (the
latter 2 are sources of carcinogenic N-nitroso com-
pounds).64,65 Cigarette smoking also has been asso-
ciated with an increased risk of gastric cancer;
however, the absence of control for confounders
such as H. pylori infection and fresh produce con-
sumption have hindered the interpretation of many
studies.66-68
Obesity may be an important risk factor for gas-
tric cancer of the cardia.69 Behavioral Risk Factor
Surveillance System data indicate that AI/AN popula-
tions from all regions have a higher prevalence of
obesity than NHW populations.70 Despite this find-
ing, proximal gastric cancer incidence was only sig-
nificantly higher in AI/ANs than in NHWs among
males in Alaska. Family history also confers an ele-
vated risk of gastric cancer. Between 10% and 30% of
TABLE 2
Gastric Cancer Incidence Rates and Rate Ratios by Age and Indian Health Service Region for American Indians/Alaska Natives
and Non-Hispanic Whites in Contract Health Service Delivery Area Counties: US, 1999-2004
IHS Region
<40 Years 40-49 Years 50-64 Years ‡65 Years
AI/AN
Ratea
NHW
Ratea RR 95% CI
AI/AN
Ratea
NHW
Ratea RR 95% CI
AI/AN
Ratea
NHW
Ratea RR 95% CI
AI/AN
Ratea
NHW
Ratea RR 95% CI
Northern Plains 1.2 0.2 5.69b 2.46-11.39 7.1 2.3 3.07b 1.60-5.39 17.5 8.4 2.09b 1.35-3.09 69.6 30.8 2.26b 1.65-3.04
Alaska 2.2 0.1 16.27b 3.24-154.70 15.0 2.6 5.73b 2.47-13.15 26.1 6.0 4.37b 2.26-8.26 134.5 31.1 4.33b 2.83-6.61
Southern Plains 0.2 0.2 0.88 0.10-3.33 5.9 2.2 2.64b 1.39-4.72 13.4 7.0 1.90b 1.27-2.77 47.0 28.0 1.68b 1.29-2.16
Pacific Coast 0.2 0.2 1.05 0.21-3.03 1.8 2.3 0.79 0.29-1.74 10.9 8.5 1.29 0.86-1.86 46.0 30.4 1.51b 1.12-2.00
East 0.3 0.3 1.08 0.03-6.33 3.9 2.8 1.40 0.29-4.16 9.5 9.8 0.97 0.35-2.12 30.6 38.1 0.80 0.38-1.50
Southwest 0.6 0.2 3.43b 1.56-6.80 3.8 2.1 1.81 0.98-3.12 17.4 7.3 2.39b 1.78-3.14 63.2 26.5 2.39b 1.94-2.91
Total 0.6 0.2 2.69b 1.82-3.83 4.9 2.4 2.05b 1.57-2.64 15.1 8.4 1.78b 1.52-2.08 59.1 31.7 1.87b 1.67-2.08
Source: Cancer registries in the Center for Disease Control’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program.
IHS indicates Indian Health Service; AI/AN, American Indians/Alaska Natives; NHW, non-Hispanic whites; RR, rate ratio; 95% CI, 95% confidence interval.
aRates are per 100,000 persons and are age-adjusted to the 2000 US standard population.
bThe RR is statistically significant (P < .05).
Years of data and registries used: 1999-2004 (41 states and the District of Columbia): Alaska,* Alabama,* Arkansas, Arizona,* California,* Colorado,* Connecticut,* the District of Columbia, Delaware, Florida,*
Georgia, Hawaii, Iowa,* Idaho,* Illinois, Indiana,* Kentucky, Louisiana,* Massachusetts,* Maine,* Michigan,* Minnesota,* Missouri, Montana,* North Carolina,* Nebraska,* New Hampshire, New Jersey, New Mex-
ico,* Nevada,* New York,* Ohio, Oklahoma,* Oregon,* Pennsylvania,* Rhode Island,* Texas,* Utah,* Washington,* Wisconsin,* West Virginia, and Wyoming*; 1999 and 2002-2004: North Dakota*; 2001-2004: South
Dakota*; 2003-2004: Mississippi* and Virginia; 2004: Tennessee (asterisks indicate states with at least 1 county designated as a Contract Health Service Delivery Area).
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patients with gastric cancer have a family history of
the disease,71-73 and twin studies have suggested that
inherited genes contribute approximately 28% of the
added risk, with environmental factors making up
the remainder.74
In summary, this report on gastric cancer in AI/
AN populations builds on previous publications by
addressing the misclassification of race and by pre-
senting incidence rates both nationwide and by
region. Results from this study suggest a need to bet-
ter characterize the burden of H. pylori among AI/
ANs and NHWs and to clarify whether this factor
alone is responsible for the disproportionate burden
of gastric cancer in AI/AN populations. Regional
differences in gastric cancer incidence in AI/AN
populations may provide an opportunity to eluci-
date risk factors and identify future means of preven-
tion.
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